En un ensayo clnico de fase 2 que evalu su uso en DM2, orforglipron redujo significativamente la HbA1c 2,10% en comparacin con 1,10% para dulaglutida y 0,43% para placebo34
It could have to do with effects that are partially mediated by sex hormones or it could have to do with sex differences in immune function. Next steps Mavromatis and colleagues intend to follow patients treated with GLP-1 receptor agonists longer to continue to assess outcomes
We said, no, if you have excess body fat, it doesn't matter if you're overweight or not that is obesity, but it may not be causing harm to your health
They lower C-reactive protein (CRP), improve markers linked to chronic inflammation, and appear to reduce inflammation in the liver, cardiovascular system, and brain